3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-amine

Catalog No. :
ACRJEN154
CAS No. :
444143-45-7
Molecular Formula :
C14H9F6N
Molecular Weight :
305.22

IUPAC Name:3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-4-amine

3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$166.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-amine
IUPAC Name3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-4-amine
MDL No.B170390
Molecular FormulaC14H9F6N
Molecular Weight305.22
SMILESNC1=CC=C(C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)C=C1
InChI KeyMGGUROGTKGUOGP-UHFFFAOYSA-N
Synonym444143-45-7 | 3',5'-Bis(trifluoromethyl)-[1,1'-biphenyl]-4-amine | 4-Amino-3',5'-bis(trifluoromethyl)biphenyl | 4-[3,5-bis(trifluoromethyl)phenyl]aniline | C14H9F6N | 3',5'-Bis(trifluoromethyl)biphenyl-4-amine | 4-[3,5-(Bis(trifluoromethyl)phenyl]aniline | 3',5'-Bis(tr
CAS No.444143-45-7
PubChem CID2782755

Safety Data

Pictogram
CorrosiveToxic
Signal Word
Danger
Hazard Statement(s)
H300-H318
Precautionary Statement(s)
P264-P270-P280-P301+P310-P305+P351+P338-P310-P321-P330-P405-P501

Synthetic Route by SureRoute

1. ACRJEN154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFUWM684 route compound structure diagram
    ACFUWM68473852-19-4 In Stock
  4. Then
  5. ACRJEN154 route product structure diagram
    ACRJEN154444143-45-7
Inquiry

2. ACRJEN154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQUXN258 route compound structure diagram
    ACQUXN258328-70-1 In Stock
  2. Plus
  3. ACECLU943 route compound structure diagram
    ACECLU94380460-73-7 In Stock
  4. Then
  5. ACRJEN154 route product structure diagram
    ACRJEN154444143-45-7
Inquiry

Comments (0)